Multiple Myeloma Archives - Cancer Trials Ireland

Name	No.	For Patients with	Purpose
Discontinuation Study	20-28	Multiple Myeloma	To assess how many patients remain in remission after 12 months of stopping maintenance therapy

Name

No.

For Patients with

Purpose

Discontinuation Study

20-28

Multiple Myeloma

To assess how many patients remain in remission after 12 months of stopping maintenance therapy

Name	No.	For Patients with	Purpose
MajesTEC-4	23-21	Newly diagnosed multiple myeloma	This is a multicenter, randomized, open-label, Phase 3 study in participants with newly diagnosed multiple myeloma to evaluate the benefits of teclistamab in combination with lenalidomide and teclistamab alone versus lenalidomide alone as maintenance therapy after autologous stem cell transplant.

Open Trials